A 2661 New York Assembly · 2023 Regular Session

Establishes the Syd O. Sotillo Sickle Cell Treatment Act

This bill creates the Syd O. Sotillo Sickle Cell Treatment Act to establish designated centers for sickle cell care excellence and outpatient treatment across the state. It designates five hospitals or hospices as centers of excellence that will provide specialized care, conduct research, and receive $200,000 annually, while also designating ten other hospitals as outpatient treatment centers that will receive $100,000 each. Additionally, the legislation modifies opioid prescribing rules to explicitly exempt patients with active sickle cell disease from restrictions that limit long-term pain medication use. These changes aim to improve access to specialized care and ensure that sickle cell patients can access necessary pain management without facing standard opioid limitations.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
Governor
Introduced Jan 26, 2023 Last action May 21, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
5
Key actions
2
Committee
3
Amendments
2
May 21, 2024
Committee
REPORTED REFERRED TO WAYS AND MEANS
lower
Mar 18, 2024
Lower · Passed
PRINT NUMBER 2661A
lower
Mar 18, 2024
Lower · Passed
AMEND (T) AND RECOMMIT TO HEALTH
lower
Jan 3, 2024
Committee
REFERRED TO HEALTH
lower
Jan 26, 2023
Committee
REFERRED TO HEALTH
lower
1 primary · 10 co-sponsors

Sponsors